- Scrip
- >>Business
- >>Financing
Finance Watch: Biopharma IPOs Regain Momentum With Slate Of New Offerings
Four Companies Went Public On 18 March, Raising $678.8m
Public Company Edition: Instil Bio, Connect Biopharma, Finch Therapeutics, Gain Therapeutics and four heath care-focused SPACs launched initial public offerings; Endo raised $1.3bn via note sale; and Rubius Therapeutics, Solid Biosciences and others priced follow-on offerings.
Biopharmaceutical companies have launched 26 initial public offerings in the US this year as of the start of the week, including four offerings that priced on 18 March and raised $678.8m for Instil Bio, Inc., Connect Biopharma Holdings Ltd., Finch Therapeutics Group and Gain Therapeutics, Inc.
The IPO market seems to be regaining its momentum after just three drug developers went public in January, followed by...